Investing Through an Uneasy Boom

Investing Through an Uneasy Boom

Our Chief Cross-Asset Strategist Serena Tang explains why investors should stay constructive in 2026, even as oil prices and geopolitics add volatility. Read more insights [https://www.morganstanley.com/insights?cid=mg-SM_CORP-insights-17607] from Morgan Stanley. ----- Transcript ----- Welcome to Thoughts on the Market. I’m Serena Tang, Morgan Stanley’s Chief Cross-Asset Strategist. Today: our mid-year market outlook across regions and asset classes. It’s Friday, May 15th, at 10am in New York. If you’ve winced at the gas pump, hesitated before booking a flight, or checked your 401(k) a little more often than usual, you already understand the forces driving markets now. Energy prices and geopolitics are creating real uncertainty. But underneath that uncertainty, companies are still investing, earnings are still holding up, and AI is becoming one of the biggest spending cycles in the global economy. That’s why our message for the rest of 2026 is – be constructive, not complacent. Let’s start with the constructive part. Across markets, macro and micro fundamentals support risk assets. In the U.S., growth should hold up. For investors, this suggests favoring stocks over core fixed income and developed-market equities — especially the U.S. – in particular. Our U.S. Equity Strategist’s S&P 500 target for mid-2027 stands at 8,300, supported by expected earnings growth of 23 percent in 2026 and 12 percent in 2027. The momentum in returns is coming from improving earnings. Now, a striking data point: the median S&P 500 company delivered a 6 percent earnings surprise in the first quarter – the strongest in four years. Earnings revisions breadth also improved sharply. AI explains a major part of that strength. It has become a capital spending story – and increasingly, a credit market story. A year ago, we projected combined capex for the biggest hyperscalers at around [$]450 billion in both 2026 and 2027. Now, that estimate has moved to roughly [$]800 billion in 2026 and [$]1.16 trillion in 2027. AI infrastructure – data centers, power, chips, networks – should shape equities, credit, rates and even commodities for years to come. But here’s where the not complacent part matters. There’s another side to the AI boom. Building all those data centers, chips, power systems and networks requires significant investment. And companies won’t fund all of it with cash. Many will borrow. That means more corporate bonds coming to market, especially from high-quality U.S. companies. Even if those companies look financially healthy, investors may demand better terms when they have so many new bonds to choose from. So, AI can support earnings, but it can also put some pressure on credit markets. Energy prices also pose major risk. Our base case assumes de-escalation and a gradual reopening of the Strait of Hormuz, but the range of possible outcomes looks unusually wide. Oil prices and the duration of the Middle East supply shock are the single largest variable in our outlook. Higher oil effectively acts like a tax on consumers and businesses alike. That’s why we recommend a balanced allocation with a risk-on tilt: overweight equities, underweight core fixed income, and hold other fixed income, commodities and cash at benchmark weight. Within equities, we favor the U.S. because earnings look strong and the risk-reward looks better than in other regions. Europe and Japan also offer upside, but Europe has more exposure to energy disruptions, and emerging markets lack a broad macro and micro narrative despite pockets of strength. This is all to say the cycle has not run out of road. But the road looks bumpier, narrower and more energy-sensitive than it looked a few months ago. Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Global Growth Faces an Energy Test

Our Global Chief Economist and Head of Macro Strategy Seth Carpenter gives his midyear outlook, highlighting why AI investment and U.S. consumers remain key growth engines amid energy shocks. Read more insights [https://www.morganstanley.com/insights?cid=mg-SM_CORP-insights-17607] from Morgan Stanley. ----- Transcript ----- Seth Carpenter: Welcome to Thoughts on the Market. I'm Seth Carpenter, Morgan Stanley's Global Chief Economist and Head of Macro Research.  Today, I want to talk about our mid-year outlook that was just published.  It's Thursday, May 14th at 10am in New York.  Oil, AI, and the consumer now sit at the center of our global economic outlook. With AI and the consumer driving economic momentum in the U.S., the key question is whether the energy shock stays manageable or changes the path for inflation, central banks, and recession risks.  We have had and maintain a fundamentally constructive view on global growth, but the energy shock brings unusually high uncertainty. It boosts inflation, it weighs on growth, and it widens the range of outcomes. We forecast global real GDP growth at 3.2 percent in 2026 and 3.4 percent in 2027. That is relative to about 3.5 percent in 2025.  So, in our baseline, growth slows modestly this year and then stabilizes and recovers. Writing a forecast is always hard but knowing what to assume about oil prices is even harder than ever now. Our base case assumes that crude returns to about $90 a barrel by the end of this year and declines further in 2027.  If, and I do mean if, that happens, the global economy can likely absorb the shock. But if the current situation persists and we do not see a normalization of shipments of oil, it could spell recession. That scenario probably sees oil prices surge through $150 a barrel, but more importantly, we could shift from a price shock to a volume shock.  The big risk is physical shortages and supply chain disruptions because it's not just energy, it's also petrochemical inputs to manufacturing and other items. Higher prices slow activity; shortages can stop it.  Exposure to the energy shock differs sharply across regions. Among the major economies, China looks the least exposed. Europe is the most exposed, and the U.S. sits in between. China built up substantial stockpiles of oil, and part of why the global oil market has not seen higher oil prices so far is that China has cut back on those imports dramatically.  Europe, on the other hand, typically faces faster energy passthrough, meaning energy prices show up much more quickly in household bills, business costs, and ultimately inflation. And Europe is a net importer of energy, so the consideration goes beyond oil to include natural gas.  The U.S. is a net exporter of petroleum products, but U.S. consumers will feel the pinch at the gas pump. But even with that in mind, U.S. growth continues to support global growth, thanks largely to strong AI-related capital spending and consumer spending that's being buoyed by the top end of the wealth distribution. We expect that momentum to continue and then ultimately to broaden out. And so we forecast U.S. real GDP growth at about 2.25 in 2026 but rising to about 2.5 percent in 2027. Both of those are up from the 2.1 percent we saw last year.  And AI CapEx sits at the center of this U.S. outlook. It includes data centers, power infrastructure, information processing equipment, software. Over time, we think this investment momentum is part of what allows a broadening out of business investment beyond AI.  That said, the energy shock has triggered global inflation. We're looking for global headline inflation to rise notably almost to 3 percent in 2026 before coming back off in 2027. But while oil and gas prices are pushing headline inflation higher, the pass-through to core, depending on the economy, seems to remain mostly limited. By 2027, we look for those effects to fade. And combined with somewhat slower growth this year, underlying inflation should soften again.  As inflation risks have moved higher, though, central banks have generally become less accommodative. We expect the Fed to now stay on hold all the way through 2026, and then if inflation really does come down, to be able to cut twice in the first half of 2027. We're looking for the ECB to hike twice this year as it grapples with this energy-led inflation, but then reverse course next year in 2027. The Bank of Japan, which had already been hiking policy, probably is set to continue that gradual hiking path.  Looking forward to the second half of this year though, global growth still does have a foundation, and the U.S. is a big part of that. AI investment and consumer spending are all what's driving the economy for now. But the energy outlook will determine how bumpy that path gets.  Thanks for listening. And if you enjoy this show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

What to Expect From the U.S.-China Summit

Our Head of Public Policy Research Ariana Salvatore goes through the main topics on the table during the meeting between Presidents Trump and Xi: Taiwan, tariffs and the Iran conflict. Read more insights [https://www.morganstanley.com/insights?cid=mg-SM_CORP-insights-17607] from Morgan Stanley. ----- Transcript ----- Ariana Salvatore: Welcome to Thoughts on the Market. I'm Ariana Salvatore, Head of Public Policy Research for Morgan Stanley.  Today, I'll be talking about expectations heading into the U.S.-China summit this week and what investors should be watching.  It's Wednesday, May 13h at 11am in Copenhagen.  Despite the importance of the upcoming summit, we think expectations for tangible progress should remain relatively modest. Reporting ahead of the meeting indicates that the discussions will focus on trade, Taiwan arms sales, and the U.S.-Iran conflict. Across the board, our base case remains an extension of the current truce with limited areas of relaxation. That's probably enough to support modest upside for risk assets in China, but likely short of the kind of breakthrough needed for a material re-rating in risk premia.  Let's start with trade. We think the discussion here is likely to skew toward phase one style commitments rather than structural policy shifts. That could include additional Chinese purchases in sectors like agriculture and aerospace, or things like high-level trade and investment pledges. Or even limited tariff relief in key areas designed to demonstrate cooperation but without fundamentally changing the competitive dynamic between the two countries.  What we don't expect is a meaningful unilateral tariff reduction from the U.S. side heading into the summit. Remember, China still faces an effective tariff rate of around 30 percent, and it benefited the most of all our trading partners when the Supreme Court struck down the IEEPA tariffs earlier this year. As we noted at the time, that lowered its effective rate by roughly 7 percentage points.  Secondly, we think the administration continues to view higher tariff levels on China versus other trading partners as a strategic imperative. Said differently, the administration appears committed to maintaining some degree of structural separation between China and other trading allies like Europe, Japan, and South Korea. We think that means a large-scale tariff reset is unlikely in the wake of the summit or in the lead up.  On Taiwan, we also see limited room for meaningful policy change. President Trump has publicly referenced Taiwan arms sales in recent comments, but we think a major concession from China would be needed for a meaningful departure from many years of U.S. policy precedent.  The third issue on the agenda is the Iran conflict and the Strait of Hormuz. Reopening the strait is likely the area of greatest uncertainty heading into the summit. The extent to which the U.S. will ask for China's help on this front and whether or not that request will be granted remains a key unknown.  But there's also a technology dimension here worth watching closely. While public reporting indicates that export controls are likely not formally part of the talks, we see a possibility that the discussion could occur, in particular in the context of rare earth relaxations from China's side.  Concessions on rare earth controls likely require some corresponding U.S. flexibility on advanced semiconductor exports, given the chips for rare earths equilibrium that we think underpins the strategic bilateral relationship. We think that's largely what's disincentivized both sides from escalating in recent months.  So, what should markets watch most closely? Aside from tangible trade arrangements or a formal extension of the truce, we think the tone will be crucial. Language around technology cooperation or an agreement to continue negotiating will be critical in assessing how both sides plan on managing the relationship moving forward.  Remember, this event is one of several potential meetings this year, so symbolic commitments toward broader structural concessions in the future could matter. For now, we think the most likely outcome is continued stabilization rather than a transformational reset. That's still constructive for markets at the margin, but probably not enough to eliminate the geopolitical overhang that continues to shape investor positioning globally. Thanks for listening. As a reminder, if you enjoy Thoughts on the Market, please take a moment to rate and review us wherever you listen and share the podcast with a friend or colleague today.

How Your Body Data Could Reshape Sectors

Our U.S. Healthcare Analyst Erin Wright discusses how health tracking and preventive diagnostics could influence healthcare costs and different industries, from fitness to retail. Read more insights [https://www.morganstanley.com/insights?cid=mg-SM_CORP-insights-17607] from Morgan Stanley. ----- Transcript ----- Welcome to Thoughts on the Market. I’m Erin Wright, Morgan Stanley’s U.S. Healthcare Services Analyst.  Today – the emergence of the self-directed patient and its implications.  It’s Tuesday, May 12th at 10am in New York.  A blood test ordered from your phone. A wearable that tracks your sleep or nudges you to move, recover, hydrate, or rethink last night’s dinner. Preventive health is moving out of the clinic and into everyday life. And that shift is becoming an investable theme.  In essence, healthcare is moving from reactive to proactive. Instead of waiting for symptoms, more consumers are using lab tests, wearables, imaging, and digital tools to spot some these risks earlier. And this shift reaches well beyond healthcare.  On our estimates, the U.S. spends about [$]3.4 trillion annually on chronic diseases, including lost economic productivity. About [$]1.4 trillion of 2024 spend was tied to preventable disease. So the big investment question is: can earlier detection and behavior change bend the cost curve?  We think expanded preventive testing, screening, and monitoring can help avoid roughly [$]200 billion to [$]800 billion of U.S. healthcare spend by 2050. That assumes preventive testing reduces preventable disease costs by about 10% to 30% based on our analysis.  Direct-to-consumer lab testing lets people order lab tests directly, often online, without starting with a traditional doctor visit. We see this as a roughly $4 billion U.S. market, which has more than doubled since 2021. And it’s no longer niche. Our AlphaWise survey found that about 34% of respondents completed a voluntary wellness lab test in the past three years. Among users, the average was 3.2 tests, suggesting this is not just a one-time behavior. The most common test was a general health profile, used by about 45 percent of recent testers.  Wearables are the other part of the story. Our survey found that 41 percent of respondents currently use a wearable or fitness device, while another 22 percent are interested in getting one. More importantly, people are acting on the data. 34 percent of wearable users today regularly change behaviors or decisions based on their device, and 52 percent even sometimes do so, based on our survey.  That creates a feedback loop. A wearable might flag poor sleep. A lab test might show elevated glucose. A digital health tool might suggest changes to diet or exercise, or follow-up care. Over time, prevention starts to feel less like an annual event and more like a daily habit.  The sector implications are broad. In healthcare, more testing may initially actually increase utilization as people follow up on results. But over time, earlier detection could obviously support lower-cost of care and better chronic disease management. That also aligns with value-based care, where providers and payers are rewarded for better outcomes and lower total costs, not just simply more services.  In consumer sectors, better health tracking could shape food choices, reduce demand for some indulgent categories, and support products tied to hydration, lower sugar, protein, and functional benefits. Fitness may also benefit as gyms evolve from just workout destinations into broader wellness platforms, with recovery and coaching, and preventive health services layered in. Imaging is another emerging area, as screening shifts from reactive diagnostics toward earlier disease detection.  Of course, there is some risk that these health tracking and consumer-driven diagnostics trends could still prove to be a wellness craze rather than the new normal. Out-of-pocket costs, privacy concerns, inconsistent interpretations, and limited repeat testing are all real issues. But consumers are clearly taking more control of their health and increasingly asking, “What can I learn before I get sick?”  Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Why AI Funding Is So Price-Insensitive

Our Global Head of Fixed Income Research Andrew Sheets explains the economic theory behind the unwavering spending on AI infrastructure. Read more insights [https://www.morganstanley.com/insights?cid=mg-SM_CORP-insights-17607] from Morgan Stanley. ----- Transcript ----- Andrew Sheets: Welcome to Thoughts on the Market. I'm Andrew Sheets, Global Head of Fixed Income Research at Morgan Stanley. Today, a uniquely price insensitive development. It's Monday, May 11th at 2pm in London. Elasticity is one of the first concepts that they teach in economics, and for good reason. It's the idea that our sensitivity to the price of something differs from item to item. If the price of pizza goes up, for example, you may decide to go out for burgers. But if the price for something essential, like electricity, or deeply desired, like tickets to see your favorite artist perform; well, if those go up a lot, you're probably going to complain, but also end up paying anyway. This latter category is what we would call inelastic. The demand for these items holds up even as the price increases, and maybe if the price increases quite a bit. And that is becoming very relevant as we all debate the AI build-out. It's not an exaggeration that the investment in AI, chips, power, and datacenters is at the center of many market conversations. It's supporting U.S. growth despite a sharp slowdown in job creation. It's supporting stock market earnings, even as uncertainty over the Iran conflict continues to percolate. Part of this importance is just the sheer size of this build-out. We estimate about $800 billion of investment by large U.S. technology companies this year, almost double their spending last year and triple their spending in 2024. But it's not just the size, it's the idea that this investment may happen almost whatever the cost. Specifically, we're looking at a desire by multiple large companies to build out large AI infrastructure all at the same time, and that's increased the price of these components. The copper needed to wire together that data center? Well, it's up about 40 percent in the last year. A gas turbine to power it? Up 50 percent. The memory to run it? It's up 150 to 300 percent over the last year alone. And yet, despite these extremely large price increases, the demand to build in AI has been accelerating. Our forecasts for 2026 spending have been consistently revised higher. And that $800 billion that we think is spent this year is set to be dwarfed by $1.1 trillion of estimated spending in 2027, based on the view of my Morgan Stanley colleagues. This idea of inelasticity or price insensitivity extends even to the costs of financing the spending. Debt costs for these companies have increased this year, and yet they continue to issue at a record pace. A quick aside as to why all this spending may be price insensitive or inelastic. AI is seen by these companies as, without exaggeration, maybe the most important technology in a decade. These companies have financial resources and the patience to wait it out, and they see gains to those who can figure out AI technology, even if the winner is not yet clear. The inelastic nature of the AI theme is a classic good news, bad news story. To the positive, it suggests real commitment to this technology and that spending won't easily be shaken by outside events. That should help buttress overall growth and should also support earnings this year – a core view of Mike Wilson and our U.S. equity strategy team. But there are also risks. It remains to be seen what returns can be generated from all of this historic investment. Robust demand for items, even as their price goes up, may cause those prices to increase even further. That's inflation happening at a time when core inflation measures are already well above the Federal Reserve's target. And if companies are less sensitive to the cost of their borrowing to fund AI, well, other companies could find their cost dragged wider in sympathy. We continue to expect record supply and modest widening in the U.S. corporate bond market. Thank you, as always, for your time. If you find Thoughts on the Market useful, let us know by leaving a review wherever you listen. And tell a friend or colleague about us today.